Goldman Sachs Group Inc Pfizer Inc Call Options Transaction History

Goldman Sachs Group Inc

$605 Billion
Q3 2024

Call Options

19 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q3 2024 Nov 14, 2024	BUY	$27.7 - $31.39 $11.9 Million - $13.5 Million	430,000 Added 106.3%	834,500 $24.2 Million
Q2 2024 Aug 13, 2024	SELL	$25.26 - $29.6 $2.07 Million - $2.43 Million	-82,000 Reduced 16.86%	404,500 $11.3 Million
Q1 2024 May 15, 2024	SELL	$25.89 - $29.73 $24.8 Million - $28.5 Million	-958,200 Reduced 66.33%	486,500 $13.5 Million
Q4 2023 Feb 13, 2024	BUY	$26.13 - $33.94 $20 Million - $26 Million	766,500 Added 113.02%	1,444,700 $41.6 Million
Q3 2023 May 14, 2024	SELL	$32.09 - $37.51 $24.6 Million - $28.8 Million	-766,500 Reduced 53.06%	678,200 $22.5 Million
Q3 2023 Nov 14, 2023	SELL	$32.09 - $37.51 $4.16 Million - $4.86 Million	-129,500 Reduced 16.03%	678,200 $22.5 Million
Q2 2023 May 14, 2024	BUY	$36.12 - $41.79 $2.96 Million - $3.43 Million	82,000 Added 11.3%	807,700 $29.6 Million
Q2 2023 Aug 14, 2023	BUY	$36.12 - $41.79 $2.96 Million - $3.43 Million	82,000 Added 11.3%	807,700 $29.6 Million
Q1 2023 May 14, 2024	SELL	$39.39 - $51.28 $44.5 Million - $57.9 Million	-1,129,100 Reduced 60.87%	725,700 $29.6 Million
Q1 2023 May 11, 2023	SELL	$39.39 - $51.28 $44.5 Million - $57.9 Million	-1,129,100 Reduced 60.87%	725,700 $29.6 Million
Q4 2022 May 14, 2024	SELL	$41.75 - $54.5 $4.1 Million - $5.35 Million	-98,100 Reduced 5.02%	1,854,800 $95.1 Million
Q4 2022 Feb 13, 2023	SELL	$41.75 - $54.5 $4.1 Million - $5.35 Million	-98,100 Reduced 5.02%	1,854,800 $95.1 Million
Q3 2022 May 14, 2024	BUY	$43.76 - $53.42 $805,184 - $982,928	18,400 Added 0.95%	1,952,900 $85.5 Million
Q3 2022 Nov 10, 2022	BUY	$43.76 - $53.42 $805,184 - $982,928	18,400 Added 0.95%	1,952,900 $85.5 Million
Q2 2022 May 14, 2024	BUY	$46.53 - $55.17 $22.8 Million - $27 Million	489,800 Added 33.9%	1,934,500 $101 Million
Q2 2022 Aug 15, 2022	SELL	$46.53 - $55.17 $4.88 Million - $5.78 Million	-104,800 Reduced 5.14%	1,934,500 $101 Million
Q1 2022 May 16, 2022	SELL	$45.75 - $56.69 $6.91 Million - $8.57 Million	-151,100 Reduced 6.9%	2,039,300 $106 Million
Q4 2021 Feb 14, 2022	SELL	$41.32 - $61.25 $1.47 Million - $2.18 Million	-35,600 Reduced 1.6%	2,190,400 $129 Million
Q3 2021 Nov 10, 2021	BUY	$39.25 - $50.42 $87.4 Million - $112 Million	2,226,000 New	2,226,000 $95.7 Million

Others Institutions Holding PFE

# of Institutions

3,256

Shares Held

3.62B

Call Options Held

77.2M

Put Options Held

122M

Vanguard Group Inc Valley Forge, PA

516M
Shares

$13.2 Billion
0.27% of portfolio
Black Rock Inc. New York, NY

424M
Shares

$10.9 Billion
0.27% of portfolio
State Street Corp Boston, MA

290M
Shares

$7.45 Billion
0.35% of portfolio
Wellington Management Group LLP Boston, MA

164M
Shares

$4.2 Billion
0.85% of portfolio
Charles Schwab Investment Management Inc San Francisco, CA

130M
Shares

$3.34 Billion
0.73% of portfolio

View Full List

About PFIZER INC

Ticker PFE
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 5,612,349,952
Market Cap $144B
Description
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...

More about PFE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Goldman Sachs Group Inc, based on Form 13F filings with the SEC.

News

Stay updated on Goldman Sachs Group Inc with notifications on news.

Account